PCSK9 and metabolic syndrome: In addition, several newly identified modulatory biomarkers, such as proprotein convertase subtilisin/kexin type 9, angiopoietin-like protein, and fibroblast growth factors, might play an important role in the regulation of dyslipidemia induced by hypothyroidism.